Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema

Creative Commons License

Borman P., Yaman A., Yasrebi S., Inanli A. P., Donmez A. A.

CLINICAL BREAST CANCER, vol.22, no.3, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1016/j.clbc.2021.08.005
  • Journal Name: CLINICAL BREAST CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: Breast cancer-related lymphedema, complete decongestive therapy, volume, quality of life, functional status, PNEUMATIC COMPRESSION PUMP, UPPER EXTREMITY LYMPHEDEMA, LYMPHATIC THERAPY, PROSPECTIVE TRIAL, PHYSIOTHERAPY, MASTECTOMY, DEPRESSION, DRAINAGE, EDEMA, WOMEN
  • Hacettepe University Affiliated: Yes

Abstract

The aim of this study was to evaluate the effects of complex decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL), in regard to volume reduction, functional status and quality-of-life (QoL). CDT in combined manner performed daily for 3 weeks, can greatly reduce the volume as well as improve the disability and impaired QoL, especially when performed earlier in patients with BCRL.